Metraipolis › archive › dc_dbb27d7692cf

Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data — Europe PMC PMID:42358828

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358828
DOI
10.32604/or.2026.077700
License (as archived)
solo-consultazione
Archived
2026-10-19T09:26:28.958Z
SHA-256 of the archived text
77f7988ccb4d38ba1341e72bd312a689613339d56e3c539e4bec2fd48de5e7dd
Stable URL of this page
https://metraipolis.com/documento/dc_dbb27d7692cf

How to cite

Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data — Europe PMC PMID:42358828 — Europe PMC (en), https://europepmc.org/article/MED/42358828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbb27d7692cf (Metraipolis archive dc_dbb27d7692cf, sha256 77f7988ccb4d38ba1341e72bd312a689613339d56e3c539e4bec2fd48de5e7dd)
BibTeX
@misc{dcdbb27d7692cf,
  title = {Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data — Europe PMC PMID:42358828},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358828},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbb27d7692cf; sha256 77f7988ccb4d38ba1341e72bd312a689613339d56e3c539e4bec2fd48de5e7dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358828. Agents can read the archived copy with the MCP tool read_document.